Scalper1 News
Generic-drug makers were the top-performing industry group Thursday and it’s easy to see why. Pfizer (PFE) announced it is buying one of the 17 stocks in the group, Hospira (HSP), for $15 billion. The $90 per share purchase price is a 39% premium over Wednesday’s close. That, alone, accounted for much of the group’s gain. Even before the announcement, generic drugs were ranked No. 9 out of 197 groups as of Thursday’s IBD. Hospira makes injectable Scalper1 News
Scalper1 News